111 Inc(us:YI)

8.58

+5.80%

Updated on 2025-04-02

Open:8.01
Close:8.58
High:8.79
Low:8.01
Prev Close:8.11
Volume:13853.00
Turnover:117669.88
Turnover Ratio:0.16%
Shares:8.57M
MarketCap:73.50M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-301920699942.42%328
2024-03-311818919642.21%168
2023-12-311919565562.29%546
2023-09-301519223192.29%255
2023-06-301718183892.16%166
2023-03-311918798922.24%239
2022-12-311920384482.44%358
2022-09-302032990043.96%4310
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Jpmorgan Chase & Co7106000.83%7090.10%
2024-03-31Greenwoods Asset Management Hong Kong Ltd.3488630.41%0
2024-03-31Barclays Plc3298000.39%0
2024-03-31Renaissance Technologies Llc1143890.13%-88631-43.66%
2024-03-31Deuterium Capital Management, Llc1000000.12%100000
2024-03-31State Street Corp986430.12%6730.69%
2024-03-31Morgan Stanley472490.06%10002.16%
2024-03-31Two Sigma Securities, Llc359680.04%21375146.47%
2024-03-31Citadel Advisors Llc340490.04%-33006-49.22%
2024-03-31Geode Capital Management, Llc331000.04%0

About

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Address:No.295 Zuchongzhi Road,Pudong New Area,3-5 Floor

Market Movers